More than 90% of patients fulfilling the diagnostic criteria for PJS and carry mutation in STK11, a tumor suppression gene [143], located at 19p13.3, which encodes for a serine/threonine kinase. The gene discussed is STK11; the disease is Peutz-Jeghers syndrome.